Ronnie in lab.jpg

LEXINGTON, Ky. (June 24, 2021) — Early in the evening of May 30, 2020, UK HealthCare trauma surgeon Dr. Zachary Warriner prepared an emergency operation to figure out the cause of a bowel obstruction. His patient, a 27-year old man, had come into the emergency department earlier that day with the vague symptoms of severe belly pain and nausea.

210607SandersBrown001.jpeg

Alzheimer’s disease wreaks emotional havoc on patients, who are robbed of their memories, their dignity, and their lives. About 75,000 Kentuckians who are 65 and older are living with Alzheimer’s disease. Nationally, there are nearly six million Americans living with Alzheimer’s. Since that number is expected to rise to nearly 14 million by 2050, Alzheimer’s will likely hit closer to home for many.

GettyImages-874789476 (1).jpeg

Memory Sunday is designated nationally as the second Sunday in June. Memory Sunday was established to raise awareness about Alzheimer’s disease and its impact on the African American community, since their risk of developing Alzheimer’s disease is two to three times higher than white Americans.

merged-sb.jpg

A study by several researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) was recently highlighted in AlzForum. The study focuses on polyamines, the nitrogen-packed aliphatic molecules produced by our own cells and found in the foods we eat. They have been described by some as anti-aging generators.

Road to Memory Sunday Flyer 8 .jpg
Raise awareness about memory loss, aging and Alzheimers disease among the Black/African American community.Please Join Us!

Program 1: May 14 - Pastor Thomas Baker, Senior Pastor of Christway MBC Louisville, KY

podcast-3939905_1920.jpg
GettyImages-1074166486.jpg

LEXINGTON, Ky. (May 5, 2021) — Collaborative research between the University of Kentucky and the University of Southern California (USC) suggests that a noninvasive neuroimaging technique may index early-stage blood-brain barrier (BBB) dysfunction associated with small vessel disease (SVD). Cerebral SVD is the most common cause of vascular cognitive impairment, with a significant proportion of cases going on to develop dementia.

GettyImages-1214872926_0.jpg

LEXINGTON, Ky. (April 29, 2021) —The 13th annual University of Kentucky Sanders-Brown Center on Aging Mind Matters Health Fair is set to take place from 10 a.m. to noon, Monday, May 3. The format will follow last year’s move to a virtual platform to ensure the continued health and safety of both the presenters and attendees. 

210423CareGiverTrain187.jpg

LEXINGTON, Ky. (April 27, 2021) — Dr. Peter Sawaya is the associate chief of Nephrology at the University of Kentucky, but it isn’t through his work there that he saw a great need in a certain area of health care. It instead is through his work on a much more personal level – as the primary caregiver for a family member living with dementia.

“I thought about it because I’m dealing with it. It is so hard,” he said.

HealthFairFlyer2021.jpg
Registration is now open for our Annual Mind Matters Health Fair.

This year's event will be held virtually.

NewMemoryClinicFPH.jpg

Sanders-Brown is the envy of Alzheimer’s research centers around the country for our leadership in the fight against dementia. We are much more than a research center, however. It our mission to help patients and their families here and now, not just those who may suffer from dementia later. Our outreach programs connect patients and their families with the resources they need to manage the day-to-day ups and downs that is life with Alzheimer’s disease.

Screen Shot 2021-03-16 at 3.51.08 PM.png
Join us for a free online viewing of the documentary SPARK

6 – 8 pm on Thursday, April the 8th, 2021
After the film, please join us for a panel discussion with local and national research experts on Lewy Body Dementia.

This event is sponsored by

The Lewy Body Dementia Association & UK Sanders-Brown Center on Aging

GettyImages-1271666425.jpg

LEXINGTON, Ky. (Feb. 25, 2021) — Spinal cord injuries (SCIs) are not only life-threatening at the time of the event, but they can also lead to secondary complications and loss of function in sensory and motor systems. Researchers at the University of Kentucky recently published a unique study focusing on SCIs in eNeuro.

GettyImages-925426264.jpg

LEXINGTON, Ky. (Feb. 5, 2021) — The early prognosis of high-risk older adults for amnestic mild cognitive impairment (aMCI), using non-invasive and sensitive neuromarkers, is key for early prevention of Alzheimer’s disease.

Oaknoll Retirement Residence, Iowa City, IA - Meghan.JPG

LEXINGTON, Ky. (Jan. 26, 2021) — Newly published research has found familiar music can elicit an extended emotional response in patients with Alzheimer’s-type dementia. The findings from this potential new approach were featured in issue three of volume 78 of the Journal of Alzheimer’s Disease.

201217AlzResearch016.JPG

LEXINGTON, Ky. (Jan. 20, 2021) — More than 5.7 million Americans live with Alzheimer’s disease and that number is projected to triple by 2050. Despite that growing number, there is not yet a cure.

Lee, Daniel_0.jpg

Daniel Lee, PhD, is an associate professor at the University of Kentucky College of Medicine Department of Neuroscience and a researcher at the UK Sanders-Brown Center on Aging, an internationally recognized Alzheimer’s Disease Research Center. He joined the UK College of Medicine in August 2019. He is also a member of the Faculty of Color Network and currently serves as co-director for the Research Education Component (REC) of the UK-ADRC.

190314VANELDIK38_0.JPG

LEXINGTON, Ky. (Nov. 24, 2020) — Linda J. Van Eldik, director of the Sanders-Brown Center on Aging at the University of Kentucky, has been named a Fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers.

BTB-UKNow_0_75_0.jpg

LEXINGTON, Ky. (Nov. 20, 2020) — The statistics on Alzheimer’s and dementia inducing brain disease are frightening to look at, and unlike research into cancer and heart disease, researchers have often been frustrated in their efforts to make progress in understanding these diseases.

200904PharmacyGrant002 (1).JPG

LEXINGTON, KY. (Oct. 27, 2020) — A $2.9 million grant from the National Institutes of Health (NIH) is supporting a multidisciplinary team of University of Kentucky researchers in continuing their work to find therapeutic strategies to resolve neurovascular inflammation and repair blood-brain barrier dysfunction in epilepsy.